Prognostication using serum levels of components of the folate metabolic pathway in patients (PTS) treated with capecitabine for advanced colorectal cancer (ACRC). Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Vincent, MD
  • Jonker, D
  • Kerr, I
  • Goel, R
  • Martin, LA
  • Gurjal, A
  • Mathews, J
  • Biagi, J
  • Knight, Gregory
  • Lam, W

publication date

  • July 15, 2004